The Alabama Center for Childhood Cancer and Blood Disorders at Children's is a component of the UAB Comprehensive Cancer Center, as designated by the National Institute of Health, is the state's only comprehensive center for pediatric blood and malignant disorders, treating 90 percent of all pediatric cancer and other blood disorders patients diagnosed in Alabama. We are the single largest provider of specialized pediatric services in Alabama for: Cancer/Leukemia Brain and Spinal Cord Tumors, pediatric bone marrow transplantation, Sickle Cell Diseases Hemophilia and Other Bleeding Disorders.
In 2010, the Division of Pediatric Hematology and Oncology provided care to:
- 130 children newly diagnosed with cancer
- 300 cancer patients actively being treated
- 1,000 survivors of childhood cancer and their families (i.e., children who were previously treated and/or those whose condition is currently being monitored)
- 13,000+ outpatient clinic visits
- 2000+ patients treated for serious blood disorders including sickle cell disease, hemophilia and bleeding disorders.
The Division of is an active member institution of Children's Oncology Group (COG), an international 200- member collaborative academic research group focused on clinical trials in childhood cancer. Recently, the Division has been awarded membership in the COG Phase I Consortium. This prestigious designation is important as the UAB Division of pediatric Hematology/Oncology is one of only 21 COG Phase I Consortium Sites in the United States and now can provide new and innovative therapies for children with cancer.
More than 1,000 cancer survivors are participants in our Taking on Life after Cancer (TLC) program. This is the only clinic in Alabama dealing with not only the medical and physical treatment, but also the emotional needs of childhood cancer and bone marrow transplant survivors.